| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | 2.61e-05 | 538 | 47 | 8 | GO:0007264 | |
| GeneOntologyBiologicalProcess | Rho protein signal transduction | 3.50e-05 | 164 | 47 | 5 | GO:0007266 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 5.71e-05 | 92 | 47 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | plasma membrane organization | 6.71e-05 | 188 | 47 | 5 | GO:0007009 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 1.36e-04 | 115 | 47 | 4 | GO:0097061 | |
| GeneOntologyBiologicalProcess | T-tubule organization | 1.81e-04 | 9 | 47 | 2 | GO:0033292 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.93e-04 | 126 | 47 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 1.99e-04 | 127 | 47 | 4 | GO:0106027 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 2.31e-04 | 132 | 47 | 4 | GO:0035249 | |
| Domain | MetalloPept_cat_dom | 1.25e-03 | 81 | 49 | 3 | IPR024079 | |
| Domain | - | 1.25e-03 | 81 | 49 | 3 | 3.40.390.10 | |
| Domain | EGF_CA | 1.49e-03 | 86 | 49 | 3 | PF07645 | |
| Domain | ADAM_spacer1 | 1.65e-03 | 23 | 49 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.65e-03 | 23 | 49 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.79e-03 | 24 | 49 | 2 | IPR013273 | |
| Domain | EGF_Ca-bd_CS | 2.10e-03 | 97 | 49 | 3 | IPR018097 | |
| Domain | ZINC_PROTEASE | 2.17e-03 | 98 | 49 | 3 | PS00142 | |
| Domain | EGF_CA | 2.23e-03 | 99 | 49 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.30e-03 | 100 | 49 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.71e-03 | 106 | 49 | 3 | IPR000152 | |
| Domain | EGF_CA | 4.02e-03 | 122 | 49 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.21e-03 | 124 | 49 | 3 | IPR001881 | |
| Domain | EGF | 4.41e-03 | 126 | 49 | 3 | PF00008 | |
| Domain | Peptidase_M12B_N | 4.70e-03 | 39 | 49 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 4.70e-03 | 39 | 49 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 4.94e-03 | 40 | 49 | 2 | PS00427 | |
| Domain | Reprolysin | 4.94e-03 | 40 | 49 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 4.94e-03 | 40 | 49 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 4.94e-03 | 40 | 49 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 4.94e-03 | 40 | 49 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 5.18e-03 | 41 | 49 | 2 | IPR001762 | |
| Domain | Growth_fac_rcpt_ | 7.95e-03 | 156 | 49 | 3 | IPR009030 | |
| Domain | Small_GTPase | 8.52e-03 | 160 | 49 | 3 | IPR001806 | |
| Pubmed | ARHGAP5 NRIP1 HDAC6 ANK2 ADAMTS9 RALBP1 SIPA1L1 MAST1 GRIN2B CNOT3 SCAI ARMC8 | 1.60e-07 | 1285 | 49 | 12 | 35914814 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22331470 | ||
| Pubmed | NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma. | 5.83e-06 | 3 | 49 | 2 | 38518721 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 19033385 | ||
| Pubmed | EGF-induced sodium influx regulates EGFR trafficking through HDAC6 and tubulin acetylation. | 1.16e-05 | 4 | 49 | 2 | 26382850 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 8660964 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 7673236 | ||
| Pubmed | ARHGAP5 CTNNAL1 HDAC6 SIPA1L1 OTUD4 CEP295 ZNF318 GPATCH8 ARMC8 | 1.80e-05 | 1084 | 49 | 9 | 11544199 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 24687993 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 25080504 | ||
| Pubmed | Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. | 2.91e-05 | 6 | 49 | 2 | 1716634 | |
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 9422736 | ||
| Pubmed | Genome-Wide Analysis in Brazilians Reveals Highly Differentiated Native American Genome Regions. | 4.07e-05 | 7 | 49 | 2 | 28100790 | |
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 6.06e-05 | 150 | 49 | 4 | 22678362 | |
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 6.96e-05 | 9 | 49 | 2 | 27325115 | |
| Pubmed | Disruption of FAT10-MAD2 binding inhibits tumor progression. | 8.69e-05 | 10 | 49 | 2 | 25422469 | |
| Pubmed | Ral GTPases regulate exocyst assembly through dual subunit interactions. | 8.69e-05 | 10 | 49 | 2 | 14525976 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 11167130 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 9.39e-05 | 168 | 49 | 4 | 30631154 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.00e-04 | 774 | 49 | 7 | 15302935 | |
| Pubmed | 1.27e-04 | 12 | 49 | 2 | 29519959 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.27e-04 | 12 | 49 | 2 | 25770910 | |
| Pubmed | Loss of the tumor suppressor BAP1 causes myeloid transformation. | 1.50e-04 | 13 | 49 | 2 | 22878500 | |
| Pubmed | 1.77e-04 | 1139 | 49 | 8 | 36417873 | ||
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 24056301 | ||
| Pubmed | 2.14e-04 | 1497 | 49 | 9 | 31527615 | ||
| Pubmed | 2.30e-04 | 16 | 49 | 2 | 15831516 | ||
| Pubmed | 2.61e-04 | 17 | 49 | 2 | 21241894 | ||
| Pubmed | 2.67e-04 | 407 | 49 | 5 | 12693553 | ||
| Pubmed | Ectodysplasin-A signaling is a key integrator in the lacrimal gland-cornea feedback loop. | 4.01e-04 | 21 | 49 | 2 | 31221639 | |
| Pubmed | 6.67e-04 | 27 | 49 | 2 | 24550280 | ||
| Pubmed | Cullin-3-KCTD10-mediated CEP97 degradation promotes primary cilium formation. | 6.67e-04 | 27 | 49 | 2 | 30404837 | |
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 7.18e-04 | 28 | 49 | 2 | 31600191 | |
| Pubmed | 7.65e-04 | 513 | 49 | 5 | 25798074 | ||
| Pubmed | 8.08e-04 | 1431 | 49 | 8 | 37142655 | ||
| Pubmed | 9.10e-04 | 1116 | 49 | 7 | 31753913 | ||
| Pubmed | RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway. | 1.40e-03 | 156 | 49 | 3 | 26170170 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 5.75e-04 | 19 | 34 | 2 | 50 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 2.53e-05 | 854 | 49 | 9 | M1533 | |
| Coexpression | GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN | 3.24e-05 | 196 | 49 | 5 | M8171 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 3.43e-05 | 888 | 49 | 9 | MM1018 | |
| Coexpression | GSE15330_HSC_VS_PRO_BCELL_DN | 3.57e-05 | 200 | 49 | 5 | M7063 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 1.19e-05 | 61 | 49 | 4 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 176 | 49 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.93e-06 | 187 | 49 | 5 | 5429ae85942b8ec3895cceb63c663de3c24ca064 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.14e-06 | 191 | 49 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-06 | 194 | 49 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | medial-2-Endothelial-Artery|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.62e-06 | 199 | 49 | 5 | 53c17c0493f82351a039bc64def191311e0f4951 | |
| ToppCell | medial-Endothelial-Artery-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.62e-06 | 199 | 49 | 5 | c455f5a2802f2ec6f0e24266de1aaf3203ca8c78 | |
| ToppCell | medial-Endothelial-Artery|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.62e-06 | 199 | 49 | 5 | 341c0be18bec66f4cc8bda232dce54edb34b9cda | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.69e-06 | 200 | 49 | 5 | c55efd997392e99068b673542f56f1a209c5a6c8 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.69e-06 | 200 | 49 | 5 | a18817d36b2b30a32e1513d36174bf98dfea2a92 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.69e-06 | 200 | 49 | 5 | 71979bbcc035d5b8882f1502b5a8ef248aaba45a | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-2|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.52e-05 | 136 | 49 | 4 | b460669c13ed43ff3885acd38ce18f75d693738d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 151 | 49 | 4 | f41c6558a5874b6464c157027fdf202257c60e5b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 3.57e-05 | 169 | 49 | 4 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 182 | 49 | 4 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.86e-05 | 183 | 49 | 4 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.97e-05 | 184 | 49 | 4 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.07e-05 | 185 | 49 | 4 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.07e-05 | 185 | 49 | 4 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-05 | 186 | 49 | 4 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 187 | 49 | 4 | 1342bc614bc4045263c2eb0a535a1dd6c64e7abe | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 187 | 49 | 4 | 7aa206262b14b9f2aaa99e59da38b96c3594d2c9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 188 | 49 | 4 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-05 | 188 | 49 | 4 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-05 | 188 | 49 | 4 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-05 | 188 | 49 | 4 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 5.51e-05 | 189 | 49 | 4 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 189 | 49 | 4 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-05 | 189 | 49 | 4 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-05 | 189 | 49 | 4 | e002dbb2138a6264be23f3b8148275a0cef351ef | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.74e-05 | 191 | 49 | 4 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-05 | 191 | 49 | 4 | 1dfcff08e01e6a695953334342bcfde04ba005ad | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-05 | 191 | 49 | 4 | 27a532a35d9e8822014f581fd56c4ca62e39f8fe | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.86e-05 | 192 | 49 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-05 | 192 | 49 | 4 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 5.86e-05 | 192 | 49 | 4 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 5.98e-05 | 193 | 49 | 4 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.98e-05 | 193 | 49 | 4 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-05 | 193 | 49 | 4 | ba484fa1f290a92ae02475a4c468b4ac840c133e | |
| ToppCell | wk_15-18|World / Celltypes from embryonic and fetal-stage human lung | 5.98e-05 | 193 | 49 | 4 | a28ff1e80e3e741739abe869df5fbd41352a1ea0 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-05 | 193 | 49 | 4 | 1e6e2d786511cc40241197368f5df20c20b882f3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.98e-05 | 193 | 49 | 4 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-05 | 194 | 49 | 4 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.10e-05 | 194 | 49 | 4 | 582db7f7fa9aa08027ae18ed607945b5d1dc908a | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 194 | 49 | 4 | 37803f4abf1aa1ad771c9cd293933003d7101e70 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.10e-05 | 194 | 49 | 4 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.10e-05 | 194 | 49 | 4 | bda89111386398a072b70e8153b2a762298a047a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 195 | 49 | 4 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.35e-05 | 196 | 49 | 4 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.47e-05 | 197 | 49 | 4 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.47e-05 | 197 | 49 | 4 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.47e-05 | 197 | 49 | 4 | 0d1afd1ad7489c071db08b3dfff598423097d7e0 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.47e-05 | 197 | 49 | 4 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.47e-05 | 197 | 49 | 4 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.47e-05 | 197 | 49 | 4 | f45a93b5ad80a16b760acbaa6467648ffc05a0d3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.47e-05 | 197 | 49 | 4 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | distal-1-Endothelial-Bronchial_Vessel_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.60e-05 | 198 | 49 | 4 | 5cd81fe1a21c0e1a7f0d5a62ddf8e422b05aedc7 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.60e-05 | 198 | 49 | 4 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.60e-05 | 198 | 49 | 4 | 13203249e5743ba2699871c184d141207e550a86 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.60e-05 | 198 | 49 | 4 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-05 | 199 | 49 | 4 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | 367C-Endothelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-05 | 199 | 49 | 4 | 636ff80938907f137e955388797072ab45289062 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.73e-05 | 199 | 49 | 4 | ddd6cad854d889d58c1e6bbcdfd96edce4fc9694 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | d62a2cb81b01ae59969e0b2bbe99c1c9cc96fdaa | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.73e-05 | 199 | 49 | 4 | 6e3a226ebba023e3e909d7a7188137da4f1fd7fc | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-05 | 199 | 49 | 4 | 29ed081bd5204a32068b420f2244f3704891547b | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 6fb81388c5045e81c3849a7136bdff3f953f044e | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-05 | 199 | 49 | 4 | c2d85f80037f209a4a329790f475d9f98f590262 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.73e-05 | 199 | 49 | 4 | bd9090c13a38a35d50f676fdf11b68eec1340bd3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 6.86e-05 | 200 | 49 | 4 | 401d50fa394fa863fa7836344110ae5c7af3250a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.86e-05 | 200 | 49 | 4 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.86e-05 | 200 | 49 | 4 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-04 | 116 | 49 | 3 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 4.69e-04 | 138 | 49 | 3 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.99e-04 | 141 | 49 | 3 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.99e-04 | 141 | 49 | 3 | 330f944b38c3170dfc79ab033fae7b9ab71e840d | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.31e-04 | 144 | 49 | 3 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|COVID-19_Severe / disease group, cell group and cell class | 6.21e-04 | 152 | 49 | 3 | e6dbf20504c4fb73d1084b587e040855335b8959 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.33e-04 | 153 | 49 | 3 | ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.33e-04 | 153 | 49 | 3 | 90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.33e-04 | 153 | 49 | 3 | a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.58e-04 | 155 | 49 | 3 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 6.83e-04 | 157 | 49 | 3 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-04 | 158 | 49 | 3 | 90ca742739a208d457db087655ba3d1c18a9da57 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.95e-04 | 158 | 49 | 3 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.21e-04 | 160 | 49 | 3 | 8bb873704895c3b35bba8af78fedbabf7df42e71 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.48e-04 | 162 | 49 | 3 | ded08da888d8c481f0f96d1e0bfd03d617966910 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.61e-04 | 163 | 49 | 3 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 7.61e-04 | 163 | 49 | 3 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.61e-04 | 163 | 49 | 3 | ba7d02db0f0e2f9916ec8db52c067c87b6917c23 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-04 | 164 | 49 | 3 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.88e-04 | 165 | 49 | 3 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | COVID-19_Mild-PLT_0|COVID-19_Mild / Disease Group and Platelet Clusters | 7.88e-04 | 165 | 49 | 3 | 083a14d3b0162cee4e79f7398b8fb739582b39ff | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-04 | 166 | 49 | 3 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.02e-04 | 166 | 49 | 3 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.02e-04 | 166 | 49 | 3 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-04 | 166 | 49 | 3 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-04 | 166 | 49 | 3 | 4586d6725403f879fc96f67be579022587ce1906 | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; HL60; HT_HG-U133A | 4.23e-06 | 199 | 49 | 6 | 1847_UP | |
| Disease | facioscapulohumeral muscular dystrophy (implicated_via_orthology) | 7.77e-06 | 3 | 48 | 2 | DOID:11727 (implicated_via_orthology) | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 2.68e-04 | 15 | 48 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 2.68e-04 | 15 | 48 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | response to angiotensin-converting enzyme inhibitor | 2.82e-04 | 78 | 48 | 3 | EFO_0005325 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 3.90e-04 | 18 | 48 | 2 | OBA_2045155 | |
| Disease | Ovarian Serous Adenocarcinoma | 6.41e-04 | 23 | 48 | 2 | C1335177 | |
| Disease | platelet crit | 8.26e-04 | 952 | 48 | 7 | EFO_0007985 | |
| Disease | pneumonia, COVID-19 | 8.34e-04 | 113 | 48 | 3 | EFO_0003106, MONDO_0100096 | |
| Disease | Epileptic encephalopathy | 1.09e-03 | 30 | 48 | 2 | C0543888 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HTCVTFLERTDEDSY | 161 | P13497 | |
| EVTHAFRSQDEFLSS | 21 | Q9H324 | |
| DYTDESEHATYDRSR | 111 | Q9BYT9 | |
| HSDTVEFYQRLSTET | 656 | O75175 | |
| NEATSSAHYVERDRF | 956 | Q9HBD1 | |
| TEHESFTATAEFREQ | 96 | P11234 | |
| SRQQHGRSETEEYSS | 526 | Q15311 | |
| RVEDFDHTSRESNYF | 426 | Q01804 | |
| DRHAVSTEAEDRSYD | 2746 | Q01484 | |
| IETSDRLDRESTSHY | 1091 | Q14517 | |
| SDHTRSEQCYRDVSD | 361 | O95461 | |
| THARETTYDRESFEN | 216 | Q9ULD2 | |
| EDSADTIRHYQSSKR | 911 | Q9NS40 | |
| YESTNISRDTHEASF | 1621 | Q5CZC0 | |
| DDSYSDYSDRSRRHS | 891 | Q9UKJ3 | |
| VTEDTDDFTRNAYRT | 156 | Q9NRQ2 | |
| DDADFVDVLHTYTRS | 211 | Q9Y5X9 | |
| AIRDYHFVNATEESD | 1481 | Q5S007 | |
| NQDSYLADDSDRSHR | 826 | P48552 | |
| EVLDSHSFERSDFSN | 461 | Q93074 | |
| YRGDREAFEETHLTS | 41 | Q9NVS9 | |
| HSHESVRRDTDAYSD | 101 | Q86XD5 | |
| DTRSDRYHHVNSYDE | 676 | Q9Y2H9 | |
| ASYQSDRSTFHSVEE | 361 | Q9H094 | |
| EVTASSRHYVDRLFD | 16 | Q8IUR7 | |
| VRQHSFSGETDDDNY | 781 | Q9P2N4 | |
| VVAADSTERYDHTTD | 386 | Q9UJP4 | |
| DFTDSAYTSHEHRER | 331 | Q9UBT7 | |
| SEHTLESYRSRSNNE | 326 | O95727 | |
| REDDHHYSVRNSDSE | 961 | P01133 | |
| DSRSYETLVDFDNHL | 176 | O43402 | |
| TRELHRESSNFDSIY | 556 | Q9UBN7 | |
| NRDFYQRSDSSSESH | 2101 | Q9C0D2 | |
| RTESFHSYRDFQTIN | 661 | Q9Y597 | |
| SSHNDRDFLTRIFTE | 76 | O14830 | |
| VASSVSEEYFEVREH | 611 | A6ND36 | |
| TSETFQALDTFEARH | 41 | Q6IMI4 | |
| DESIYNSQREHFFTS | 1586 | O43166 | |
| AFNEETHSYEIRTTS | 246 | Q9NVD3 | |
| SYYRRTHSDASDDEA | 1166 | Q13017 | |
| HSSFDEAYFRTRTDR | 111 | Q8N957 | |
| VREYVNSTSEESHDE | 311 | Q8NBU5 | |
| SSASVSHYEFSRVRE | 41 | Q6PCB0 | |
| HGSRRFSYSEAERES | 86 | Q5K4L6 | |
| YYSHESTSEEREALR | 441 | Q8TBP0 | |
| SDEIEDYTHRFNTED | 206 | Q8N9R8 | |
| DRRSSVDRYFSADHC | 631 | Q5VUA4 | |
| GHTEFTDEVYQNESR | 926 | Q9NZM1 | |
| VYDISEHRRSFTHSD | 931 | Q13224 |